Safe Drugs and the Cost of Good Intentions

Abstract

Sophisticated data-mining tools are now available that permit real-time analysis of spontaneous reports of adverse drug reactions. These authors from the European Medicines Agency write that these developments are good news, but there are a number of unintended but foreseeable consequences.